Differential expression of OPRGs after sevoflurane anesthesia.
We first performed differential expression analysis of 200 OPRGs after sevoflurane anesthesia. We obtained 33 DEGs with the adjusted p < 0.05 and |log2(FC)|>1, of which COX4l1, CS, CYB5A, DLST, ECH1, ECHS1, ISCA1, OPA1, CPT1A, ETFB, and TIMM10 were highly expressed after sevoflurane anesthesia, and the remaining DEGs were highly expressed after sevoflurane anesthesia (Fig. 1A). Protein-protein interaction network analysis based on the String database revealed a close linkage between most genes (Fig. 1B).
Data quality was analyzed through tSNE and PCA analysis between the control and anesthesia groups.
To explore the characteristics of OPRGs expression profiles after sevoflurane anesthesia, we performed unsupervised clustering analysis to identify anesthesia subtypes based on OPRGs expression levels. The results showed that two clusters were clearly classified, and samples were classified into cluster A (control) and cluster B (anesthesia) (Fig. 2A). The PCA results further demonstrate the excellent grouping effect (Fig. 2B). In addition, we mapped OPRGs expression heatmaps and found that OPRGs were expressed at higher levels in cluster B (anesthesia) compared to cluster A (control).
The correlation between the expression of CPT1A and inflammatory factors.
To explore the correlation between CPT1A and inflammatory factors, we performed Pearson analysis between two groups. The results showed that patients in cluster B (anesthesia) had higher expression of CPT1A and inflammatory factors (IL-1β, IL-6 and TNF-α) (Figs. 3A–C), suggesting that groups after sevoflurane anesthesia have higher inflamation activity.
The expression of inflammatory factors was lower under the condition of low expression of CPT1A.
After treatment with the anesthetic drug sevoflurane, the mRNA and protein level of CPT1A in HK2 cells were detected. It was found that the expression level of CPT1A was up-regulated after sevoflurane anesthesia (Fig. 4A-B). Then, CPT1A overexpression and knockdown HK2 cells were established (Fig. 4C-D). In order to verify the effect of CPT1A in sevoflurane treatment. QRT-PCR assay was used to detect the mRNA expression level of inflammatory factors (Fig. 4E-G), and western blot was used to detect the expression level of inflammatory factors. It was verified that the expression of inflammatory factors was lower under the condition of low expression of the OPRG gene CPT1A (Fig. 4H).
CPT1A affects renal cell activity through the pyroptosis pathway.
Pyrotosis is a type of programmed cell death that has gradually been defined in recent years. Unlike apoptosis, pyroptosis is an inflammatory cell death that primarily involves the release of inflammatory mediators during cell death, leading to an inflammatory response. Considering the abnormal expression of inflammation factors, pyroptosis indicators (Gasdermin D, caspase-1) were detected. It was verified that the expression of pyroptosis indicators was lower under the condition of low expression of the OPRG gene (Fig. 5A-C). Pyroptosis was detected by TUNEL assay, which indicated that CPT1A induced pyroptosis in renal cells (Fig. 5D). The above results showed that CPT1A is the critical gene that affects renal cell activity through the pyroptosis pathway.